Presenting Firebrick Pharma
Firebrick Pharma Pty Ltd is a private Australian company founded by two successful pharmaceutical and biotechnology executives with a background in pharmaceutical and antiviral drug development. (Our Team) Firebrick's mission is to bring to market the world's first nasal spray that kills viruses.
The nasal spray is protected by a granted patent that is wholly-owned by Firebrick. Over the last several years, we have completed all formulation, packaging and manufacturing development. We have also tested it against all the known viruses responsible for the common cold and shown that it rapidly kills (inactivates) those viruses without harming the nasal passages.
We now intend to complete a clinical trial to demonstrate that the product is safe and effective; based on the trial results, we expect to file for marketing aproval in Australia, after which the product could be available for sale.